NetworkNewsBreaks – Lexaria Bioscience Corp.’s
Post# of 721
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced its development of additional enhancements for its industry-leading DehydraTECH(TM) platform that delivers THC onset of action in less than 10 minutes in human pilot testing. According to the update, volunteers in recent human subjective pilot tests reported onset in less than 10 minutes from edibles formulated with this latest DehydraTECH innovation. This enhanced version of the delivery platform shows onset that is roughly twice as fast as traditional DehydraTECH and four to six times faster than generic industry formulations.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer